Spyre Therapeutics Inc. (SYRE) — Net Asset Quality Index
Spyre Therapeutics Inc. (SYRE) has a Net Asset Quality Index of 93.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.17 Billion minus total liabilities of $71.86 Million yields net assets of $1.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read SYRE total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Spyre Therapeutics Inc. Net Asset Quality Index Over Time (2013–2025)
This chart shows how Spyre Therapeutics Inc.'s Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 93.9%, representing net assets of $1.10 Billion against total assets of $1.17 Billion USD. For live market cap and overall valuation, see SYRE stock market capitalisation.
Annual Net Asset Quality Index for Spyre Therapeutics Inc. (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Spyre Therapeutics Inc. from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See SYRE net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.0% | $715.24 Million | $777.78 Million | $62.55 Million | ▲ +6.9 pp |
| 2024 | 85.1% | $517.80 Million | $608.48 Million | $90.68 Million | ▲ +31.3 pp |
| 2023 | 53.8% | $184.02 Million | $341.86 Million | $157.84 Million | ▼ -16.9 pp |
| 2022 | 70.7% | $50.30 Million | $71.14 Million | $20.84 Million | ▼ -5.7 pp |
| 2021 | 76.4% | $83.94 Million | $109.93 Million | $25.98 Million | ▼ -10.2 pp |
| 2020 | 86.5% | $139.83 Million | $161.62 Million | $21.79 Million | ▲ +14.3 pp |
| 2019 | 72.2% | $60.08 Million | $83.18 Million | $23.10 Million | ▼ -14.5 pp |
| 2018 | 86.7% | $67.43 Million | $77.74 Million | $10.31 Million | ▼ -3.0 pp |
| 2017 | 89.8% | $50.34 Million | $56.08 Million | $5.74 Million | ▼ -4.1 pp |
| 2016 | 93.9% | $62.97 Million | $67.06 Million | $4.10 Million | ▲ +0.5 pp |
| 2015 | 93.4% | $36.10 Million | $38.65 Million | $2.55 Million | ▲ +29.5 pp |
| 2014 | 63.9% | $1.87 Million | $2.93 Million | $1.06 Million | ▼ -5.4 pp |
| 2013 | 69.3% | $3.19 Million | $4.60 Million | $1.41 Million | — |